Psychiatric and cognitive characteristics of individuals with Danon disease (LAMP2 gene mutation)

被引:19
|
作者
Yardeni, Maya [1 ]
Weisman, Omri [1 ,2 ]
Mandel, Hanna [3 ]
Weinberger, Ronnie [1 ]
Quarta, Giovanni [4 ]
Salazar-Mendiguchia, Joel [5 ,6 ]
Garcia-Pavia, Pablo [7 ]
Jose Lobato-Rodriguez, Maria [8 ]
Fajardo Simon, Lourdes [8 ]
Freimark, Dov [9 ,10 ]
Arad, Michael [9 ,10 ]
Gothelf, Doron [1 ,2 ,10 ]
机构
[1] Edmond & Lily Safra Childrens Hosp, Behav Neurogenet Ctr, Sheba Med Ctr, IL-52621 Tel Hashomer, Israel
[2] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel
[3] Technion Israel Inst Technol, Childrens Hosp, Metab Unit, Rambam Hlth Care Campus, Haifa, Israel
[4] ASST Papa Giovanni XXIII, Cardiol Dept, Bergamo, Italy
[5] Bellvitge Univ Hosp, Heart Failure & Transplant Program, Cardiomyopathy Unit, Barcelona, Spain
[6] Hlth Code, Cardiovasc Genet, La Coruna, Spain
[7] Hosp Univ Puerta de Hierro Majadahonda, Dept Cardiol, Madrid, Spain
[8] Hosp Univ Puerta de Hierro Majadahonda, Madrid, Spain
[9] Sheba Med Ctr, Leviev Heart Ctr, Tel Hashomer, Israel
[10] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel
关键词
cardiomyopathy; cognition; Danon disease; IQ; LAMP2; psychiatric comorbidities; Wolff-Parkinson-White syndrome; CARDIOMYOPATHY; DEPRESSION; EFFICACY; BATTERY;
D O I
10.1002/ajmg.a.38320
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Danon disease (DD) is a rare X-linked disorder caused by loss-of-function mutations in the LAMP2 gene, which encodes lysosome-associated membrane protein. It is characterized by the triad of hypertrophic cardiomyopathy, myopathy, and intellectual disability. Whereas the molecular and pathophysiological mechanisms underlying this disorder have been previously reported and continue to be explored, the cognitive deficits and psychiatric comorbidities manifested in DD remain an understudied topic. We systematically assessed cognitive abilities and psychiatric comorbidities in 13 males and females. Most of the participants in our cohort (n=9; 75%) had an IQ score within the normal range, while only one participant had intellectual disability. Participants' performance on the Cognitive Neuropsychiatric Battery (CNB) showed only mildly impaired cognitive abilities in most modules, except in the executive functioning test, which was low compared to healthy controls. Of note, 69% of the participants met criteria for at least one psychiatric disorder, mainly mood and anxiety disorders, occurring alone or in combination in the same patient. The results of the present study challenge earlier reports suggesting that mental retardation is a core constituent in DD. Of importance, it underscores the need to refer Danon patients to psychiatric assessment.
引用
收藏
页码:2461 / 2466
页数:6
相关论文
共 50 条
  • [1] Danon disease due to a novel splice mutation in the LAMP2 gene
    Nadeau, Amelie
    Therrien, Christian
    Karpati, George
    Sinnreich, Michael
    MUSCLE & NERVE, 2008, 37 (03) : 338 - 342
  • [2] LAMP2 Microdeletions in Patients With Danon Disease
    Yang, Zhao
    Funke, Birgit H.
    Cripe, Linda H.
    Vick, G. Wesley, III
    Mancini-Dinardo, Debora
    Pena, Liana S.
    Kanter, Ronald J.
    Wong, Brenda
    Westerfield, Brandy H.
    Varela, Jaquelin J.
    Fan, Yuxin
    Towbin, Jeffrey A.
    Vatta, Matteo
    CIRCULATION-CARDIOVASCULAR GENETICS, 2010, 3 (02) : 129 - 137
  • [3] Danon disease: A focus on processing of the novel LAMP2 mutation and comments on the beneficial use of peripheral white blood cells in the diagnosis of LAMP2 deficiency
    Majer, F.
    Vlaskova, H.
    Krol, L.
    Kalina, T.
    Kubanek, M.
    Stolnaya, L.
    Dvorakova, L.
    Elleder, M.
    Sikora, J.
    GENE, 2012, 498 (02) : 183 - 195
  • [4] Early onset of cardiomyopathy and intellectual disability in a girl with Danon disease associated with a de novo novel mutation of the LAMP2 gene
    Sugie, Kazuma
    Yoshizawa, Hiroyuki
    Onoue, Kenji
    Nakanishi, Yoko
    Eura, Nobuyuki
    Ogawa, Megumu
    Nakano, Tomoya
    Sakaguchi, Yasuhiro
    Hayashi, Yukiko K.
    Kishimoto, Toshifumi
    Shima, Midori
    Saito, Yoshihiko
    Nishino, Ichizo
    Ueno, Satoshi
    NEUROPATHOLOGY, 2016, 36 (06) : 561 - 565
  • [5] Danon disease caused by two novel mutations of the LAMP2 gene: implications for two ends of the clinical spectrum
    Hong, Daojun
    Shi, Zhihong
    Zhang, Wei
    Wang, Zhaoxia
    Yuan, Yun
    CLINICAL NEUROPATHOLOGY, 2012, 31 (04) : 224 - 231
  • [6] Case Report: A Novel LAMP2 Splice-Altering Mutation Causes Cardiac-Only Danon Disease
    Li, Zongzhe
    Ma, Fei
    Li, Rui
    Xiao, Zhichao
    Zeng, Hesong
    Wang, Dao Wen
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [7] Altered Splicing of LAMP2 in a Multigenerational Family from Latvia Affected by Danon Disease
    Stavusis, Janis
    Micule, Ieva
    Grinfelde, Ieva
    Zdanovica, Anna
    Pudulis, Janis
    Valeina, Sandra
    Sepetiene, Svetlana
    Lace, Baiba
    Inashkina, Inna
    MEDICINA-LITHUANIA, 2024, 60 (01):
  • [8] A family with Danon disease caused by a splice site mutation in LAMP2 that generates a truncated protein
    Zhou, Nianwei
    Cui, Jie
    Zhao, Weipeng
    Jiang, Yingying
    Zhu, Wenqing
    Tang, Lu
    Li, Xuejie
    Sun, Minmin
    Pan, Cuizhen
    Shu, Xianhong
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2019, 7 (03):
  • [9] Danon disease and a new mutation of the LAMP-2 gene in a Spanish family
    Modrego, P. J.
    Lopez-Pison, F. J.
    Alfaro, J.
    NEUROLOGIA, 2017, 32 (05): : 331 - 332
  • [10] Identification of a novel LAMP2 mutation responsible for X-chromosomal dominant Danon disease
    Horváth, J
    Ketelsen, UP
    Geibel-Zehender, A
    Boehm, N
    Olbrich, H
    Korinthenberg, R
    Omran, H
    NEUROPEDIATRICS, 2003, 34 (05) : 270 - 273